USD 7.56 billion
Report ID:
SQMIG35A2186 |
Region:
Global |
Published Date: March, 2025
Pages:
219
|Tables:
59
|Figures:
78
Global Pharmaceutical Automation Market size was valued at USD 7.56 billion in 2023 and is poised to grow from USD 8.38 billion in 2024 to USD 19.03 billion by 2032, growing at a CAGR of 10.8% during the forecast period (2025-2032).
With the use of analytics and software, pharmacy automation devices are revolutionising the retail pharmacy industry worldwide. Automation has increased the industry's profitability while simultaneously increasing its efficiency by a factor of ten. The automation has significantly reduced the amount of medicine wasted, which has reduced the cost per dose. Additionally, it has made workflow management simple for pharmacists while putting a stronger emphasis on patient happiness.
The cost of prescription and over-the-counter medications has been soaring in recent years. The benefits of automation have been effectively used by pharmaceutical businesses to maintain or grow output without sacrificing quality or safety.
Pharmaceutical businesses can now safely ramp up production and construct production lines more quickly and flexibly thanks to automation. Pre-existing trends like flexible automation, digitalization, batch production, and personalisation have been amplified by the COVID-19 pandemic.
US Pharmaceutical Automation Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 7.56 billion
Largest Segment
fully-automatic
Fastest Growth
fully-automatic
Growth Rate
10.8% CAGR
To get more reports on the above market click here to Buy The Report
Global Pharmaceutical Automation Market is segmented by Offering, Mode of Automation, End User, Application and region. Based on Offering, the market is segmented into Hardware, Software and Services. Based on Mode of Automation, the market is segmented into Fully-Automated Systems and Semi-Automated Systems. Based on End User, the market is segmented into Pharmaceutical Companies, Research Laboratories, Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs). Based on Application, the market is segmented into Drug Discovery, Drug Development, Clinical Trials, Manufacturing, Packaging and Quality Control. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The market is divided into semi-automatic and fully-automatic systems based on the level of automation. During the forecast period, the fully automatic category is anticipated to post a higher CAGR. The installation of complete automation systems in end-use industries including chemicals & materials, metals & mining, oil & gas, and paper & pulp has been credited with the segment's quick rise. Companies in these industries can handle activities on-site and in offices more effectively with the help of fully automated systems. The labor-intensive nature of mining and exploration activities necessitates the effective operation of management systems, made possible by ERP solutions. These businesses also employ robots and automated technology to supplement the human workforce in demanding jobs and increase production.
The market is divided into the pharmaceutical sector and the biotech industry based on the end user. The pharmaceutical automation market is anticipated to be dominated by the pharmaceutical industry segment in 2022. The increasing use of continuous improvement processes (CIP) to increase production flexibility and efficiency and decrease waste is credited with the substantial market share of this sector. Furthermore, to fill security holes and shield healthcare and pharmaceutical manufacturing networks from outside threats, major technology companies like Microsoft, IBM, and Google are working to build automation and cloud solutions for the pharmaceutical and healthcare sector.
To get detailed analysis on other segments, Request For Free Sample Report
On the basis of region, it is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa (MEA). The pharmaceutical automation market is anticipated to be dominated by Asia-Pacific in 2022, followed by Europe and North America. The significant market share held by Asia-Pacific is attributable to China, Japan, and Singapore's high levels of technical robotics awareness. The Asia-Pacific market for pharmaceutical automation solutions is driven in part by the region's strong pharmaceutical manufacturing sector. North America dominated the market and took home the largest percentage of revenue, amounting to more than 54.5%. Among the main forces behind the region's growth are the region's advanced healthcare system, improvements in patient management, and hospital management systems. According to a report in Drug Store News, automation and other forms of technology have been more prevalent over the past 15 months for both prescribers and pharmacists, with 66% of prescribers reporting this. The COVID-19 pandemic has fueled the growth of technology adoption, according to many technology vendors, who also claim that pharmacy automation is the future.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Investment to Develop Pharmaceutical Infrastructure to Bolster Market Growth
Stringent Regulations to Hinder Market Growth
Request Free Customization of this report to help us to meet your business objectives.
SkyQuest's ABIRAWA (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analysis, globalization of the pharmaceutical industry is another element boosting the global market for pharmacy automation. Globally, there are more people in their senior years. As a result, both the number of prescriptions written and the number of life-threatening and chronic diseases are increasing. The market for pharmacy automation has expanded greatly over the past few years and is anticipated to expand even more during the anticipated time frame. Elderly individuals are becoming more prevalent in the world. As a result, more medications are being prescribed for conditions that are commonly known to be fatal.
The rising knowledge of technology's advantages is projected to lead to growth in the worldwide pharmacy automation industry. The use of automation systems in the healthcare sector, such as automated dispensing systems, table-top counters and compounding systems, labelling and packing systems, and storage and retrieval systems, will boost the pharmacy automation market.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 7.56 billion |
Market size value in 2032 | USD 19.03 billion |
Growth Rate | 10.8% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Pharmaceutical Automation Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Pharmaceutical Automation Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Pharmaceutical Automation Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Pharmaceutical Automation Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Pharmaceutical Automation Market size was valued at USD 6.11 Billion in 2023 and is poised to grow from USD 6.6 Billion in 2024 to USD 12.24 Billion by 2032, growing at a CAGR of 8.02% during the forecast period (2025-2032).
The sector is very segmented because it is largely centred in the western hemisphere (Europe and North America). Strategic agreements between hospitals/pharmacies and software companies as well as mergers and acquisitions of smaller businesses by larger players are the key drivers of this industry. 'Siemens AG', 'Rockwell Automation, Inc.', 'ABB Ltd.', 'Emerson Electric Co.', 'General Electric Co.', 'Mitsubishi Electric Corporation', 'Honeywell International Inc.', 'Schneider Electric SE', 'Yokogawa Electric Corporation', 'Omron Corporation', 'FANUC Corporation', 'KUKA AG', 'Bosch Packaging Technology', 'Marchesini Group S.p.A.', 'Optel Group', 'Seidenader Maschinenbau GmbH', 'Wuxi Biologics (Cayman) Inc.', 'Zenith Technologies (a Cognizant company)', 'Gerresheimer AG', 'Thermo Fisher Scientific Inc.', 'AmerisourceBergen Corporation declared in January 2023 that it has successfully completed the acquisition of PharmaLex Holding GmbH. AmerisourceBergen Corporation's growth plan is strengthened by the purchase of PharmaLex, which expands the company's expertise in specialty services and global platform of pharma manufacturer services capabilities. ', 'October 2022 Omnicell, Inc. (Nasdaq: OMCL), a top provider of medication management and adherence technologies for health systems and pharmacies, announced today the launch of Specialty Pharmacy Services, a turnkey product with specialized services to set up, run, and optimize a specialty pharmacy program. ', 'Today was the 2022 Investor Day for Omnicell, Inc. (Nasdaq: OMCL), a leading supplier of prescription administration and adherence technologies to pharmacies and hospitals, which was held in September 2022. The company gave a thorough description of its unique business model and differentiated approach during the event. It also shared details about its Advanced Services portfolio, ESG strategy, and long-term financial objectives.'
The rising use of robots in pharmaceutical manufacturing, government programmes to support industrial development, rising investments in modernising traditional production facilities, and rising consumer demand for secure and digitalized production processes are all factors contributing to the growth of this market.
The rising need for equipment that lowers pharmaceutical mistakes is fueling the expansion of the worldwide pharmacy automation market.
On the basis of region, it is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa (MEA). The pharmaceutical automation market is anticipated to be dominated by Asia-Pacific in 2022, followed by Europe and North America. The significant market share held by Asia-Pacific is attributable to China, Japan, and Singapore's high levels of technical robotics awareness. The Asia-Pacific market for pharmaceutical automation solutions is driven in part by the region's strong pharmaceutical manufacturing sector. North America dominated the market and took home the largest percentage of revenue, amounting to more than 54.5%. Among the main forces behind the region's growth are the region's advanced healthcare system, improvements in patient management, and hospital management systems. According to a report in Drug Store News, automation and other forms of technology have been more prevalent over the past 15 months for both prescribers and pharmacists, with 66% of prescribers reporting this. The COVID-19 pandemic has fueled the growth of technology adoption, according to many technology vendors, who also claim that pharmacy automation is the future.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A2186
[email protected]
USA +1 351-333-4748